Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development

Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1‐AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatic...

Full description

Saved in:
Bibliographic Details
Published inMolecular carcinogenesis Vol. 54; no. 11; pp. 1275 - 1282
Main Authors Wen, Juan, Liu, Yao, Liu, Jibin, Liu, Li, Song, Ci, Han, Jing, Zhu, Liguo, Wang, Cheng, Chen, Jianguo, Zhai, Xiangjun, Shen, Hongbin, Hu, Zhibin
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.11.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1‐AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1‐AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1‐AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case‐control study of 1300 HBV‐positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1‐AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01–1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71–0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC. © 2014 Wiley Periodicals, Inc.
AbstractList Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1‐AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1‐AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1‐AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case‐control study of 1300 HBV‐positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1‐AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01–1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71–0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC. © 2014 Wiley Periodicals, Inc.
Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1-AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1-AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1-AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case-control study of 1300 HBV-positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1-AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR=1.18, 95% CI=1.01-1.38, P=0.035) and HBV clearance (adjusted OR=0.83, 95% CI=0.71-0.96, P=0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC.
Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1-AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1-AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1-AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case-control study of 1300 HBV-positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1-AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01-1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71-0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC.Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1-AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1-AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1-AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case-control study of 1300 HBV-positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1-AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01-1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71-0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC.
Author Liu, Yao
Liu, Li
Shen, Hongbin
Liu, Jibin
Song, Ci
Hu, Zhibin
Wang, Cheng
Han, Jing
Zhu, Liguo
Zhai, Xiangjun
Wen, Juan
Chen, Jianguo
Author_xml – sequence: 1
  givenname: Juan
  surname: Wen
  fullname: Wen, Juan
  organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
– sequence: 2
  givenname: Yao
  surname: Liu
  fullname: Liu, Yao
  organization: Pathology Center and Department of Pathology, Soochow University, Suzhou, China
– sequence: 3
  givenname: Jibin
  surname: Liu
  fullname: Liu, Jibin
  organization: Department of Hepatobiliary Surgery, Nantong Tumor Hospital, Nantong, China
– sequence: 4
  givenname: Li
  surname: Liu
  fullname: Liu, Li
  organization: Digestive Endoscopy Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
– sequence: 5
  givenname: Ci
  surname: Song
  fullname: Song, Ci
  organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
– sequence: 6
  givenname: Jing
  surname: Han
  fullname: Han, Jing
  organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
– sequence: 7
  givenname: Liguo
  surname: Zhu
  fullname: Zhu, Liguo
  organization: Department of Infection Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China
– sequence: 8
  givenname: Cheng
  surname: Wang
  fullname: Wang, Cheng
  organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
– sequence: 9
  givenname: Jianguo
  surname: Chen
  fullname: Chen, Jianguo
  organization: Qidong Liver Cancer Institute, Qidong, China
– sequence: 10
  givenname: Xiangjun
  surname: Zhai
  fullname: Zhai, Xiangjun
  organization: Department of Infection Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China
– sequence: 11
  givenname: Hongbin
  surname: Shen
  fullname: Shen, Hongbin
  organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
– sequence: 12
  givenname: Zhibin
  surname: Hu
  fullname: Hu, Zhibin
  organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25110835$$D View this record in MEDLINE/PubMed
BookMark eNqN0d1u0zAUB3ALDbFuIPEEyBI33KTYjpM4l6X7KFUp0gZM4sZynRPmkdiZ7YztEXhrkm4MqQKJK3_od86x9T9Ae9ZZQOglJVNKCHvb6iljjJAnaEJJKRJWcL6HJkSUZUJLUeyjgxCuCKG0yMgztM8ySolIswn6eXzbeQjBOIuve2WjiSqaG8DRKxNx47TBxg6r_YaHoYl2lRm2Z-sZ_ro-O6LJ7JwOoG56sBrwxsVLvHj3ZbwCHceuylb4EjoVnYam6RvlsVZeG-tahSu4gcZ1Ldj4HD2tVRPgxcN6iD6fHH-aL5LVx9P389kq0VzkJCk16IpzVeucKVaTIieiprqGTZ3RTBVa0JpkoLQG4GLDSQk1qYrhKFJFNE8P0Zv7vp131z2EKFsTxqcpC64PkhYpEzRLCfsPyliZUpaWA329Q69c7-3wka1iecq5GNSrB9VvWqhk502r_J38ncefidq7EDzUj4QSOUYtWy23UQ90ukP1Njtnx-iavxUk9wU_TAN3_2wsP8x3vAkRbh-98t9lXqRFJi_Wp_JiuVyx5eJEnqe_AGpkyBM
CitedBy_id crossref_primary_10_1371_journal_pone_0132352
crossref_primary_10_1667_RADE_20_00157_1
crossref_primary_10_1177_1179299X17737301
crossref_primary_10_18632_oncotarget_8411
crossref_primary_10_1016_j_mrrev_2016_10_002
crossref_primary_10_1038_s41598_018_26217_7
crossref_primary_10_1002_cam4_2160
crossref_primary_10_1186_s12885_018_4795_6
crossref_primary_10_2147_OTT_S250028
crossref_primary_10_1002_cam4_3373
crossref_primary_10_18632_aging_205523
crossref_primary_10_1186_s12876_023_02961_7
crossref_primary_10_1111_jvh_12821
crossref_primary_10_1089_gtmb_2021_0053
crossref_primary_10_18632_oncotarget_14334
crossref_primary_10_3892_ijo_2019_4909
crossref_primary_10_18632_oncotarget_10012
crossref_primary_10_3389_fviro_2022_849349
crossref_primary_10_4254_wjh_v7_i28_2781
crossref_primary_10_1002_hep_31284
crossref_primary_10_3389_fgene_2019_00696
crossref_primary_10_2147_PGPM_S325349
crossref_primary_10_18632_oncotarget_9854
crossref_primary_10_2147_JIR_S331727
crossref_primary_10_3748_wjg_v28_i25_2823
crossref_primary_10_1038_srep39516
crossref_primary_10_1371_journal_pone_0173700
crossref_primary_10_7717_peerj_9452
crossref_primary_10_1038_s41588_019_0455_2
crossref_primary_10_1093_bib_bbae327
crossref_primary_10_7717_peerj_8624
Cites_doi 10.1038/nbt.1663
10.1016/j.ccr.2008.10.005
10.1016/j.ajpath.2012.08.043
10.1038/ng.2483
10.1016/j.ccr.2012.01.001
10.1002/path.4195
10.1371/journal.pone.0035145
10.1093/hmg/ddr301
10.4161/cbt.4.1.1375
10.1002/hep.24563
10.4065/82.8.967
10.1038/ng.348
10.1128/JVI.02655-12
10.1101/gad.1800909
10.1053/j.gastro.2006.08.026
10.1111/j.1442-2050.2008.00846.x
10.1038/ng2142
10.1371/journal.pgen.1000214
10.1126/science.1143767
10.1016/j.jhep.2012.04.031
10.1053/j.gastro.2013.01.002
10.1016/S0140-6736(03)14964-1
10.1086/651114
10.1002/hep.24799
10.1110/ps.9.9.1743
10.1006/geno.1999.6040
10.1111/j.1399-0039.2004.00327.x
10.1042/CBI20100506
10.1006/jmbi.2000.3841
10.1159/000336913
10.1038/nature06904
10.1016/j.molcel.2009.08.008
ContentType Journal Article
Copyright 2014 Wiley Periodicals, Inc.
2015 Wiley Periodicals, Inc.
Copyright_xml – notice: 2014 Wiley Periodicals, Inc.
– notice: 2015 Wiley Periodicals, Inc.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7TO
8FD
FR3
H94
P64
RC3
7X8
7U9
DOI 10.1002/mc.22200
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
Virology and AIDS Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Virology and AIDS Abstracts
DatabaseTitleList
Genetics Abstracts
Genetics Abstracts
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-2744
EndPage 1282
ExternalDocumentID 3837274601
25110835
10_1002_mc_22200
MC22200
ark_67375_WNG_WJJL2JHF_S
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Jiangsu Province Clinical Science and Technology Projects
  funderid: BL2012008
– fundername: National Key Basic Research Program For Youth
  funderid: 2013CB911400
– fundername: National Science Foundation for Distinguished Young Scholars of China
  funderid: 81225020
– fundername: Foundation for the Program for New Century Excellent Talents in University
  funderid: NCET‐10‐0178
– fundername: Foundation of Jiangsu Province for Distinguished Young Scholars
  funderid: BK2012042
– fundername: National Program for Support of Top‐notch Young Professionals, Foundation for the Author of National Excellent Doctoral Dissertation
  funderid: 201081
– fundername: Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province
– fundername: Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GLUZI
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V2E
V8K
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7TO
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
H94
P64
RC3
7X8
7U9
ID FETCH-LOGICAL-c4860-9cecd44afc62a2f07608f1cfebf515a7c81f05eaccee48b409ef0d7cce83a0c43
IEDL.DBID DR2
ISSN 0899-1987
1098-2744
IngestDate Thu Jul 10 21:45:45 EDT 2025
Thu Jul 10 22:39:34 EDT 2025
Sun Jul 13 04:30:21 EDT 2025
Thu Apr 03 06:52:49 EDT 2025
Thu Apr 24 23:00:37 EDT 2025
Tue Jul 01 00:38:38 EDT 2025
Wed Jan 22 16:20:00 EST 2025
Wed Oct 30 09:56:27 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords HCC
eQTLs
ZNRD1
susceptibility
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2014 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4860-9cecd44afc62a2f07608f1cfebf515a7c81f05eaccee48b409ef0d7cce83a0c43
Notes ark:/67375/WNG-WJJL2JHF-S
ArticleID:MC22200
National Science Foundation for Distinguished Young Scholars of China - No. 81225020
Foundation for the Program for New Century Excellent Talents in University - No. NCET-10-0178
Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)
National Key Basic Research Program For Youth - No. 2013CB911400
Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province
Foundation of Jiangsu Province for Distinguished Young Scholars - No. BK2012042
istex:44C4E6D95413A97042BF87E9CEEB8EED7854B9C9
National Program for Support of Top-notch Young Professionals, Foundation for the Author of National Excellent Doctoral Dissertation - No. 201081
Jiangsu Province Clinical Science and Technology Projects - No. BL2012008
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25110835
PQID 1722263448
PQPubID 105347
PageCount 8
ParticipantIDs proquest_miscellaneous_1732815302
proquest_miscellaneous_1722931239
proquest_journals_1722263448
pubmed_primary_25110835
crossref_primary_10_1002_mc_22200
crossref_citationtrail_10_1002_mc_22200
wiley_primary_10_1002_mc_22200_MC22200
istex_primary_ark_67375_WNG_WJJL2JHF_S
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2015
PublicationDateYYYYMMDD 2015-11-01
PublicationDate_xml – month: 11
  year: 2015
  text: November 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Austin
PublicationTitle Molecular carcinogenesis
PublicationTitleAlternate Mol. Carcinog
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23:1494-1504.
Grishin NV. C-terminal domains of Escherichia coli topoisomerase I belong to the zinc-ribbon superfamily. J Mol Biol 2000; 299:1165-1177.
Hu L, Zhai X, Liu J, et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012; 55:1426-1431.
Juan AH, Kumar RM, Marx JG, et al. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36:61-74.
Hong L, Han Y, Li S, et al. Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells. Cell Biol Int 2011; 35:321-324.
Shih TC, Tien YJ, Wen CJ, et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012; 57:584-591.
Tam OH, Aravin AA, Stein P, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008; 453:534-538.
Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-595.
Feng GS. Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox. Cancer Cell 2012; 21:150-154.
Szabo G, Lippai D. Molecular hepatic carcinogenesis: impact of inflammation. Dig Dis 2012; 30:243-248.
Hong L, Han Y, Shi R, et al. ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005; 4:60-64.
Wurdinger T, Tannous BA, Saydam O, et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14:382-393.
Guo W, Zhao YP, Jiang YG, et al. ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1. Dis Esophagus 2008; 21:730-736.
Holt N, Wang J, Kim K, et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28:839-847.
Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947.
Hernandez-Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 2013; 144:512-527.
Zheng Z, Ke X, Wang M, et al. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 2013; 87:5645-5656.
Chung YL, Wu ML. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis. J Pathol 2013; 230:377-387.
Veyrieras JB, Kudaravalli S, Kim SY, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008; 4:e1000214.
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917.
Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007; 39:1217-1224.
Panzitt K, Tschernatsch MM, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132:330-342.
Fan W, Wang Z, Kyzysztof F, et al. A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region. Genomics 2000; 63:139-141.
Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64:631-649.
Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82:967-975.
Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54:1679-1689.
Jiang DK, Sun J, Cao G, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013; 45:72-75.
Chen HT, Legault P, Glushka J, et al. Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription. Protein Sci 2000; 9:1743-1752.
Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 2011; 20:3884-3892.
Ballana E, Senserrich J, Pauls E, et al. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis 2010; 50:1022-1032.
Cobleigh MA, Robek MD. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol 2013; 182:21-28.
Liu Y, Pan S, Liu L, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012; 7:e35145.
2009; 23
2007; 39
2004; 64
2009; 41
2013; 87
2013; 45
2000; 9
2000; 63
2008; 14
2013; 144
2011; 54
2011; 35
2000; 299
2008; 4
2012; 57
2012; 55
2013; 182
2012; 30
2009; 36
2007; 317
2010; 28
2007; 132
2011; 20
2005; 4
2007; 82
2008; 21
2013; 230
2008; 453
2012; 7
2012; 21
2003; 362
2010; 50
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_21_1
e_1_2_7_20_1
References_xml – reference: Hu L, Zhai X, Liu J, et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012; 55:1426-1431.
– reference: Wurdinger T, Tannous BA, Saydam O, et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14:382-393.
– reference: Szabo G, Lippai D. Molecular hepatic carcinogenesis: impact of inflammation. Dig Dis 2012; 30:243-248.
– reference: Cobleigh MA, Robek MD. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol 2013; 182:21-28.
– reference: Tam OH, Aravin AA, Stein P, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008; 453:534-538.
– reference: Juan AH, Kumar RM, Marx JG, et al. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36:61-74.
– reference: Zheng Z, Ke X, Wang M, et al. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 2013; 87:5645-5656.
– reference: Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-595.
– reference: Feng GS. Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox. Cancer Cell 2012; 21:150-154.
– reference: Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947.
– reference: Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 2011; 20:3884-3892.
– reference: Liu Y, Pan S, Liu L, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012; 7:e35145.
– reference: Hong L, Han Y, Shi R, et al. ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005; 4:60-64.
– reference: Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007; 39:1217-1224.
– reference: Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54:1679-1689.
– reference: Guo W, Zhao YP, Jiang YG, et al. ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1. Dis Esophagus 2008; 21:730-736.
– reference: Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23:1494-1504.
– reference: Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64:631-649.
– reference: Shih TC, Tien YJ, Wen CJ, et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012; 57:584-591.
– reference: Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917.
– reference: Veyrieras JB, Kudaravalli S, Kim SY, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008; 4:e1000214.
– reference: Panzitt K, Tschernatsch MM, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132:330-342.
– reference: Ballana E, Senserrich J, Pauls E, et al. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis 2010; 50:1022-1032.
– reference: Hong L, Han Y, Li S, et al. Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells. Cell Biol Int 2011; 35:321-324.
– reference: Jiang DK, Sun J, Cao G, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013; 45:72-75.
– reference: Grishin NV. C-terminal domains of Escherichia coli topoisomerase I belong to the zinc-ribbon superfamily. J Mol Biol 2000; 299:1165-1177.
– reference: Hernandez-Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 2013; 144:512-527.
– reference: Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82:967-975.
– reference: Chen HT, Legault P, Glushka J, et al. Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription. Protein Sci 2000; 9:1743-1752.
– reference: Holt N, Wang J, Kim K, et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28:839-847.
– reference: Chung YL, Wu ML. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis. J Pathol 2013; 230:377-387.
– reference: Fan W, Wang Z, Kyzysztof F, et al. A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region. Genomics 2000; 63:139-141.
– volume: 57
  start-page: 584
  year: 2012
  end-page: 591
  article-title: MicroRNA‐214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma‐derived growth factor in human hepatoma
  publication-title: J Hepatol
– volume: 453
  start-page: 534
  year: 2008
  end-page: 538
  article-title: Pseudogene‐derived small interfering RNAs regulate gene expression in mouse oocytes
  publication-title: Nature
– volume: 21
  start-page: 730
  year: 2008
  end-page: 736
  article-title: ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1
  publication-title: Dis Esophagus
– volume: 63
  start-page: 139
  year: 2000
  end-page: 141
  article-title: A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region
  publication-title: Genomics
– volume: 20
  start-page: 3884
  year: 2011
  end-page: 3892
  article-title: A genome‐wide association study of chronic hepatitis B identified novel risk locus in a Japanese population
  publication-title: Hum Mol Genet
– volume: 39
  start-page: 1217
  year: 2007
  end-page: 1224
  article-title: Population genomics of human gene expression
  publication-title: Nat Genet
– volume: 28
  start-page: 839
  year: 2010
  end-page: 847
  article-title: Human hematopoietic stem/progenitor cells modified by zinc‐finger nucleases targeted to CCR5 control HIV‐1 in vivo
  publication-title: Nat Biotechnol
– volume: 54
  start-page: 1679
  year: 2011
  end-page: 1689
  article-title: Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans
  publication-title: Hepatology
– volume: 82
  start-page: 967
  year: 2007
  end-page: 975
  article-title: Natural history of hepatitis B virus infection: an update for clinicians
  publication-title: Mayo Clin Proc
– volume: 317
  start-page: 944
  year: 2007
  end-page: 947
  article-title: A whole‐genome association study of major determinants for host control of HIV‐1
  publication-title: Science
– volume: 299
  start-page: 1165
  year: 2000
  end-page: 1177
  article-title: C‐terminal domains of Escherichia coli topoisomerase I belong to the zinc‐ribbon superfamily
  publication-title: J Mol Biol
– volume: 230
  start-page: 377
  year: 2013
  end-page: 387
  article-title: Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus‐related hepatocarcinogenesis
  publication-title: J Pathol
– volume: 9
  start-page: 1743
  year: 2000
  end-page: 1752
  article-title: Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription
  publication-title: Protein Sci
– volume: 4
  start-page: e1000214
  year: 2008
  article-title: High‐resolution mapping of expression‐QTLs yields insight into human gene regulation
  publication-title: PLoS Genet
– volume: 23
  start-page: 1494
  year: 2009
  end-page: 1504
  article-title: Long noncoding RNAs: functional surprises from the RNA world
  publication-title: Genes Dev
– volume: 30
  start-page: 243
  year: 2012
  end-page: 248
  article-title: Molecular hepatic carcinogenesis: impact of inflammation
  publication-title: Dig Dis
– volume: 87
  start-page: 5645
  year: 2013
  end-page: 5656
  article-title: Human microRNA hsa‐miR‐296‐5p suppresses enterovirus 71 replication by targeting the viral genome
  publication-title: J Virol
– volume: 7
  start-page: e35145
  year: 2012
  article-title: A genetic variant in long non‐coding RNA HULC contributes to risk of HBV‐related hepatocellular carcinoma in a Chinese population
  publication-title: PLoS One
– volume: 55
  start-page: 1426
  year: 2012
  end-page: 1431
  article-title: Genetic variants in human leukocyte antigen/DP‐DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development
  publication-title: Hepatology
– volume: 132
  start-page: 330
  year: 2007
  end-page: 342
  article-title: Characterization of HULC, a novel gene with striking up‐regulation in hepatocellular carcinoma, as noncoding RNA
  publication-title: Gastroenterology
– volume: 362
  start-page: 1907
  year: 2003
  end-page: 1917
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
– volume: 4
  start-page: 60
  year: 2005
  end-page: 64
  article-title: ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase
  publication-title: Cancer Biol Ther
– volume: 41
  start-page: 591
  year: 2009
  end-page: 595
  article-title: A genome‐wide association study identifies variants in the HLA‐DP locus associated with chronic hepatitis B in Asians
  publication-title: Nat Genet
– volume: 21
  start-page: 150
  year: 2012
  end-page: 154
  article-title: Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox
  publication-title: Cancer Cell
– volume: 182
  start-page: 21
  year: 2013
  end-page: 28
  article-title: Protective and pathological properties of IL‐22 in liver disease: implications for viral hepatitis
  publication-title: Am J Pathol
– volume: 64
  start-page: 631
  year: 2004
  end-page: 649
  article-title: An update of the HLA genomic region, locus information and disease associations: 2004
  publication-title: Tissue Antigens
– volume: 144
  start-page: 512
  year: 2013
  end-page: 527
  article-title: Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma
  publication-title: Gastroenterology
– volume: 45
  start-page: 72
  year: 2013
  end-page: 75
  article-title: Genetic variants in STAT4 and HLA‐DQ genes confer risk of hepatitis B virus‐related hepatocellular carcinoma
  publication-title: Nat Genet
– volume: 36
  start-page: 61
  year: 2009
  end-page: 74
  article-title: Mir‐214‐dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells
  publication-title: Mol Cell
– volume: 35
  start-page: 321
  year: 2011
  end-page: 324
  article-title: Role of ZNRD1 (zinc ribbon domain‐containing 1) in angiogenesis of leukaemia cells
  publication-title: Cell Biol Int
– volume: 50
  start-page: 1022
  year: 2010
  end-page: 1032
  article-title: ZNRD1 (zinc ribbon domain‐containing 1) is a host cellular factor that influences HIV‐1 replication and disease progression
  publication-title: Clin Infect Dis
– volume: 14
  start-page: 382
  year: 2008
  end-page: 393
  article-title: miR‐296 regulates growth factor receptor overexpression in angiogenic endothelial cells
  publication-title: Cancer Cell
– ident: e_1_2_7_13_1
  doi: 10.1038/nbt.1663
– ident: e_1_2_7_23_1
  doi: 10.1016/j.ccr.2008.10.005
– ident: e_1_2_7_27_1
  doi: 10.1016/j.ajpath.2012.08.043
– ident: e_1_2_7_12_1
  doi: 10.1038/ng.2483
– ident: e_1_2_7_33_1
  doi: 10.1016/j.ccr.2012.01.001
– ident: e_1_2_7_28_1
  doi: 10.1002/path.4195
– ident: e_1_2_7_31_1
  doi: 10.1371/journal.pone.0035145
– ident: e_1_2_7_11_1
  doi: 10.1093/hmg/ddr301
– ident: e_1_2_7_17_1
  doi: 10.4161/cbt.4.1.1375
– ident: e_1_2_7_30_1
  doi: 10.1002/hep.24563
– ident: e_1_2_7_4_1
  doi: 10.4065/82.8.967
– ident: e_1_2_7_10_1
  doi: 10.1038/ng.348
– ident: e_1_2_7_20_1
  doi: 10.1128/JVI.02655-12
– ident: e_1_2_7_21_1
  doi: 10.1101/gad.1800909
– ident: e_1_2_7_29_1
  doi: 10.1053/j.gastro.2006.08.026
– ident: e_1_2_7_16_1
  doi: 10.1111/j.1442-2050.2008.00846.x
– ident: e_1_2_7_25_1
  doi: 10.1038/ng2142
– ident: e_1_2_7_24_1
  doi: 10.1371/journal.pgen.1000214
– ident: e_1_2_7_15_1
  doi: 10.1126/science.1143767
– ident: e_1_2_7_19_1
  doi: 10.1016/j.jhep.2012.04.031
– ident: e_1_2_7_3_1
  doi: 10.1053/j.gastro.2013.01.002
– ident: e_1_2_7_2_1
  doi: 10.1016/S0140-6736(03)14964-1
– ident: e_1_2_7_14_1
  doi: 10.1086/651114
– ident: e_1_2_7_9_1
  doi: 10.1002/hep.24799
– ident: e_1_2_7_5_1
  doi: 10.1110/ps.9.9.1743
– ident: e_1_2_7_8_1
  doi: 10.1006/geno.1999.6040
– ident: e_1_2_7_7_1
  doi: 10.1111/j.1399-0039.2004.00327.x
– ident: e_1_2_7_18_1
  doi: 10.1042/CBI20100506
– ident: e_1_2_7_6_1
  doi: 10.1006/jmbi.2000.3841
– ident: e_1_2_7_26_1
  doi: 10.1159/000336913
– ident: e_1_2_7_22_1
  doi: 10.1038/nature06904
– ident: e_1_2_7_32_1
  doi: 10.1016/j.molcel.2009.08.008
SSID ssj0011750
Score 2.281761
Snippet Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1275
SubjectTerms Alleles
Carcinoma, Hepatocellular - genetics
Case-Control Studies
Cell Line, Tumor
DNA-Binding Proteins - genetics
eQTLs
Female
Gene loci
Genetic Predisposition to Disease - genetics
Genotype
HCC
Hep G2 Cells
Hepatitis
Hepatitis B virus
Hepatitis B virus - pathogenicity
Hepatitis B, Chronic - genetics
Hepatitis B, Chronic - virology
Humans
Liver cancer
Liver Neoplasms - genetics
Male
Middle Aged
Polymorphism, Single Nucleotide - genetics
Quantitative Trait Loci - genetics
Ribonucleic acid
RNA
RNA, Antisense - genetics
RNA, Long Noncoding - genetics
RNA, Messenger - genetics
susceptibility
ZNRD1
Title Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development
URI https://api.istex.fr/ark:/67375/WNG-WJJL2JHF-S/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmc.22200
https://www.ncbi.nlm.nih.gov/pubmed/25110835
https://www.proquest.com/docview/1722263448
https://www.proquest.com/docview/1722931239
https://www.proquest.com/docview/1732815302
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NbxMxEB2hIhAXPgqUQEFGQnDadD-cZHMMpSGKSA4ppRUcLNtrQ1XihXYjFU78ASR-I7-EGXt3q6KCEKdVkoky64z93qyfZwCeaERlnWkZ5VxmEe0ERnmW9EkJwA1HhFW-1-Fs3p_s8elB76BWVdJZmFAfon3gRjPDr9c0waU62TorGrrUXcS2mNJ1kmoRH1q0laOoAKV_vILpRER5dVN3Nk63mi-eQ6LLNKinF9HM86zVw874BrxrHA5qk6PuqlJd_fW3Wo7_d0c34XrNRtkohM8tuGTcOlwJ_Sm_rMPVWb3zfhu-75zWklnHPq-k82fTcKVk1GOiYgiJh-zQ4dW9Z650P7_90CXBIlvMR-ztfPEiwbdGuwka1V1RmMIgYZPnb1gjCHNMuoJ9QICsStpQIIUs09TsyJVLyYozfdMd2BvvvN6eRHUrh0hTl6toqI0uOJdW91OZWtoOzG2irVEWCZUc6DyxcQ9BADGb5wqTTmPjYoAv80zGmmd3YQ2dN_eAGW4xKy0GfUk7hgUJZZQcIu1KLJE_1YFnzd8qdF3nnIbiowgVmlOx1MKPcwcet5afQm2PC2ye-shoDeTxEWnhBj2xP38p9qfTV-l0Mha7HdhsQkfUy8CJQHaI9DbDFBh_q_0YJzANonSmXAUbdD7Nhn-zydI8oQZPHdgIYdk6RDki8Wj01AfXH29FzLb99f6_Gj6Aa0gPe-Hk5SasVccr8xApWKUe-cn2C9VSLH4
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED9Nm4C9DBgwCgOMhOApXf61TcVTGSuhtHnoNjZNSJbjOGza6oyRSoMnvgASn5FPwp2dZBoaCPEUpb2oF_fs3-985zuAZxJRWQZSOFEoAocigU4UeF3KBAhViAibml6Hk6Qb74aj_c7-Arysz8LY-hDNhhvNDLNe0wSnDemNi6qhM9lGcHPRX1-iht7Gn5o2taOoBKXZYEGHwiHPuq486_ob9ZOXsGiJhvX8KqJ5mbca4BnehA-1yjbf5Lg9L9O2_PpbNcf_fKdbsFIRUjawFnQbFpRehWu2ReWXVbg-qYLvd-D71nmVNavZp7nQ5ngaLpaM2kyUDFHxiB1pvOqPTBf657cfsiBkZNNkwA6S6WsPPxpseyhUNUZhKdoJi1-9Z3VOmGZCZ-wQMbIsKKZASbJMUr8jXcwEyy5SnO7C7nBrZzN2qm4OjqRGV05fKpmFochl1xd-ThHBKPdkrtIcOZXoycjL3Q7iAMJ2GKXod6rczXp4GwXClWFwDxZReXUfmApzdEyzXldQ0DCjXJlU9JF5eTnxv7QFL-r_lcuq1DkNxQm3RZp9PpPcjHMLnjaSp7a8xxUyz41pNALi7JjS4Xodvpe84Xuj0dgfxUO-3YL12nZ4tRJ85kgQkeEG6AXjbzVf4xymQRRaFXMrg8r7Qf9vMoEfedTjqQVr1i4bhchNJCqNmhrr-uOr8MmmuT74V8EncCPemYz5-G3y7iEsI1vs2IOY67BYns3VI2RkZfrYzLxfek0wmQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6hVlRceJRXoMAiITg59SuJcwxNQwiNhVJKq3JYrde7bVWyLsWRCif-ABK_kV_CzK7tqqggxMlKMo7H69n9vvHMzgA8k4jKMpLCS2IReRQJ9JIo6FImQKxiRNjM9jqcpt3xTjzZ6-xVWZW0F8bVh2heuNHMsOs1TfCTXK-fFw2dyzZim4_u-jL-Z0IWPZw1paOoAqV9v4L-hEeOdV141g_X6zMvQNEyjerZZTzzIm21uDO6AR9qjV26yXF7UWZt-fW3Yo7_d0s34XpFR9nA2c8tuKLMKlx1DSq_rMLKtAq934bvm2dVzqxhnxbC2M1puFQyajJRMsTEI3Zk8GgOmCnMz28_ZEG4yGbpgO2ns2GAXw22AxSq2qKwDK2EjV--Z3VGmGHC5OwQEbIsKKJAKbJMUrcjU8wFy88TnO7Azmjz3cbYq3o5eJLaXHl9qWQex0LLbihCTfHARAdSq0wjoxI9mQTa7yAKIGjHSYZep9J-3sOPSSR8GUd3YQmVV_eBqVijW5r3uoJChjllymSij7wr0MT-sha8qB8rl1WhcxqKj9yVaA75XHI7zi142kieuOIel8g8t5bRCIjTY0qG63X4bvqK704mW-FkPOLbLVirTYdX68BnjvQQ-W2EPjBeq_kZZzANojCqWDgZVD6M-n-TicIkoA5PLbjnzLJRiJxEItKoqTWuP94Kn27Y44N_FXwCK2-HI771On3zEK4hVey4XZhrsFSeLtQjpGNl9tjOu1_m8S9R
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+quantitative+trait+loci+in+long+non-coding+RNA+ZNRD1-AS1+influence+both+HBV+infection+and+hepatocellular+carcinoma+development&rft.jtitle=Molecular+carcinogenesis&rft.au=Wen%2C+Juan&rft.au=Liu%2C+Yao&rft.au=Liu%2C+Jibin&rft.au=Liu%2C+Li&rft.date=2015-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0899-1987&rft.eissn=1098-2744&rft.volume=54&rft.issue=11&rft.spage=1275&rft_id=info:doi/10.1002%2Fmc.22200&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3837274601
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-1987&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-1987&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-1987&client=summon